Renaissance Technologies
ENTX icon

Renaissance Technologies’s Entera Bio ENTX Stock Holding History

Renaissance Technologies’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$422K Sell
144,900
-223,947
-61% -$598K ﹤0.01% 2681
2026
Q2 		$653K Sell
368,847
-104,595
-22% -$131K ﹤0.01% 2500
2026
Q1 		$526K Buy
473,442
+365,441
+338% +$513K ﹤0.01% 2581
2025
Q4 		$210K Buy
108,001
+19,601
+22% +$46K ﹤0.01% 2871
2025
Q3 		$170K Buy
88,400
+24,100
+37% +$46.1K ﹤0.01% 3164
2025
Q2 		$122K Buy
64,300
+1,000
+2% +$1.98K ﹤0.01% 3273
2025
Q1 		$108K Buy
63,300
+1,500
+2% +$3.26K ﹤0.01% 3187
2024
Q4 		$131K Buy
61,800
+600
+1% +$1.12K ﹤0.01% 3242
2024
Q3 		$116K Buy
61,200
+3,600
+6% +$6.39K ﹤0.01% 3233
2024
Q2 		$106K Sell
57,600
-17,300
-23% -$37.9K ﹤0.01% 3173
2024
Q1 		$125K Buy
74,900
+17,500
+30% +$19.3K ﹤0.01% 3328
2023
Q4 		$34K Buy
57,400
+34,000
+145% +$23.2K ﹤0.01% 3509
2023
Q3 		$17K Buy
23,400
+7,300
+45% +$5.38K ﹤0.01% 3536
2023
Q2 		$14K Buy
16,100
+5,700
+55% +$4.87K ﹤0.01% 3806
2023
Q1 		$12K Sell
10,400
-129,200
-93% -$129K ﹤0.01% 3872
2022
Q4 		$102K Buy
139,600
+118,300
+555% +$85.6K ﹤0.01% 3610
2022
Q3 		$22K Buy
+21,300
New +$32.1K ﹤0.01% 3885
2022
Q1 		– Sell
-40,100
Closed -$113K – 4154
2021
Q4 		$113K Buy
+40,100
New +$150K ﹤0.01% 3654
2021
Q2 		– Sell
-120,407
Closed -$459K – 3534
2021
Q1 		$459K Buy
120,407
+48,221
+67% +$111K ﹤0.01% 2934
2020
Q4 		$78K Buy
+72,186
New +$79.8K ﹤0.01% 3284

Other funds holding ENTX

SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
Signature Estate & Investment Advisors
Signature Estate & Investment Advisors Los Angeles, California $5.67B AUM 20.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

Renaissance Technologies's ENTX Position: Q3 2026 in Review

Renaissance Technologies reduced its Entera Bio (ENTX) stake by 61% in Q3 2026, selling an estimated $598K and leaving 144,900 shares worth $422K. The position accounts for ﹤0.01% of the portfolio, ranked #2681.

Renaissance Technologies first reported a position in ENTX in Q4 2020 and has held it in 20 quarters since. The position peaked at $653K in Q2 2026. 12 funds tracked by Wall St. Rank hold ENTX as of Q3 2026.

  • Renaissance Technologies held 144,900 shares of Entera Bio worth $422K as of Q3 2026.
  • Renaissance Technologies sold 223,947 Entera Bio shares in Q3 2026, an estimated $598K.
  • Entera Bio made up ﹤0.01% of Renaissance Technologies's portfolio in Q3 2026, its #2681 holding.
  • Renaissance Technologies first reported a position in Entera Bio in Q4 2020 and has held it in 20 quarters since.
  • Renaissance Technologies's Entera Bio position peaked at $653K in Q2 2026.
  • 12 funds tracked by Wall St. Rank held Entera Bio as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.